Something I learned at the MBCN conference is that the Patient Protection and Affordable Care Act of 2010 (PPACA, a.k.a. HCR), will require that private insurance companies cover the routine costs of medical care for patients participating in approved clinical trials.
Medicare does so already, said Dr. Tatiana Prowell, an oncologist on the Johns Hopkins faculty who spoke at the meeting. Indeed, it says so on a CMS document.
The Association of Community Cancer Centers provides a readable section on the relevant changes, including definitions of “routine costs” and what are “approved trials” according to the new law.
All for now –